Loading organizations...
Loading organizations...
Biomedical company researching aging and developing resilience drugs.
Rejuvenate Biomed has raised $18.2M across 1 funding round.
Rejuvenate Biomed has raised $18.2M in total across 1 funding round.
Rejuvenate Biomed has raised $18.2M in total across 1 funding round.
Rejuvenate Biomed's investors include Rejuveron Life Sciences, Vesalius Biocapital.
Rejuvenate Biomed has raised $18.2M across 1 funding round. Most recently, it raised $18.2M Series B in October 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 12, 2021 | $18.2M Series B | Rejuveron Life Sciences, Vesalius Biocapital |